1. Home
  2. EVCM vs NVAX Comparison

EVCM vs NVAX Comparison

Compare EVCM & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverCommerce Inc.

EVCM

EverCommerce Inc.

HOLD

Current Price

$11.83

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVCM
NVAX
Founded
2006
1987
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.1B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
EVCM
NVAX
Price
$11.83
$6.55
Analyst Decision
Hold
Hold
Analyst Count
8
9
Target Price
$11.50
$10.78
AVG Volume (30 Days)
315.5K
3.5M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
$718,038,000.00
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
$3.17
Revenue Growth
22.13
20.27
52 Week Low
$7.66
$5.01
52 Week High
$12.34
$11.55

Technical Indicators

Market Signals
Indicator
EVCM
NVAX
Relative Strength Index (RSI) 74.55 39.20
Support Level $9.11 $6.57
Resistance Level $10.12 $6.84
Average True Range (ATR) 0.49 0.22
MACD 0.39 0.05
Stochastic Oscillator 98.61 28.00

Price Performance

Historical Comparison
EVCM
NVAX

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: